Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Xanthine
Therapeutic Area : Rheumatology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults
Details : Xanthine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Gout.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 25, 2019
Lead Product(s) : Xanthine
Therapeutic Area : Rheumatology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Xanthine
Therapeutic Area : Rheumatology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.
Details : Xanthine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Gout.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 25, 2019
Lead Product(s) : Xanthine
Therapeutic Area : Rheumatology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable